Pierre Fabre announced on Thursday, May 28, a nearly EUR 50 million (USD 58 million) investment to double production capacity at its Avène plant in southern France by 2029. The project will modernize and expand the facility, which is entirely dedicated to manufacturing and packaging products under the Eau Thermale Avène brand, as the company seeks to meet strong international demand, particularly in China and the United States.
The Pierre Fabre Group aims to double the site’s annual production capacity from 100 million to 200 million units by 2029.
The company said the expansion and modernization of the plant, dedicated to its flagship skincare brand, forms part of a broader EUR 250 million industrial investment program spanning 2023 to 2027.
The Avène unit, which employs 330 people, houses manufacturing, packaging, and a warehouse, supplemented by two external logistics sites.
In 2025, Pierre Fabre generated EUR 3.2 billion in revenue, with international markets accounting for 71% of sales. The group, which employs 10,000 people worldwide, manufactures nearly 90% of its products in France.
The group’s dermo-cosmetics sales rose by 2.6% compared with 2024, driven in particular by strong performance from the Eau Thermale Avène brand, which grew 3.9% at constant exchange rates over the year.
Pierre Fabre’s dermo-cosmetics portfolio also includes Ducray, Dexeryl, Klorane, A-Derma, René Furterer, Same Cosmetics, and Elgydium.
